FTC Detects Cancer Screening Monopoly

Law360, New York (July 7, 2006, 12:00 AM EDT) -- The Federal Trade Commission filed a complaint Friday against Hologic Inc., saying the medical device maker’s $32 million purchase of rival Fischer Imaging Corp.’s breast cancer screening business would harm consumers by eliminating the only significant competition.

However, the FTC also filed a consent decree along with the suit, meaning the charges were dropped after Hologic agreed to sell its assets related to prone stereotactic breast biopsy systems to Siemens AG within the next five days.

Siemens, a medical imaging company, is well positioned to manufacture...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.